Is HRT Safe Now? What the FDA's 2025 Hormone Therapy Update Means for Women in Mumbai
By Dr. Pallavi Kulkarni, MBBS, DGO, DNB (OB-GYN), DFP, MRCOG (UK), Fellowship in IVF · Over 16 years of practice in Kandivali East ·
If you are in your 40s or 50s, and the hot flushes, broken sleep, and mood swings have started taking over your days, you have probably heard mixed things about hormone therapy. For years the message was simple and a little frightening: HRT causes cancer, stay away. Many women in Mumbai quietly suffered through menopause because of that fear.
In late 2025, that message changed.
After reviewing newer evidence and an expert panel, the United States Food and Drug Administration (FDA), one of the most respected medical regulators in the world, decided to remove some of its strongest warnings from hormone therapy medicines. The official announcement came on 10 November 2025.
So what does this actually mean for you, sitting in Kandivali or anywhere in Mumbai, trying to decide whether hormone therapy is right for you? Let us walk through it in plain language.
Quick answer: The FDA removed its boxed warnings on menopausal hormone therapy in November 2025. The old heart-disease, breast-cancer, and dementia warnings were too broad, based mainly on data from older women. For women who begin before 60 or within 10 years of their last period, risks are smaller than previously stated. It still needs a proper medical assessment with your gynaecologist.
“Most women who walk into my OPD in Kandivali in their mid-40s and 50s have been told something scary about HRT by a friend, a family member, or an old internet article. Part of my job now is to slow the conversation down, look at their actual situation, and decide together. The FDA update has made that conversation easier, not because hormones are now risk-free but because we are not starting from fear.”
- Dr. Pallavi Kulkarni, MBBS, DGO, DNB (OB-GYN), DFP, MRCOG (UK), Fellowship in IVF
What exactly did the FDA change?
Hormone therapy medicines used to carry what doctors call a “boxed warning”, the strongest type of safety alert the FDA can put on a medicine. That warning bundled together risks like heart disease, breast cancer, and memory problems (dementia), and it applied to almost every form of hormone therapy, even mild vaginal creams.
On 10 November 2025, the FDA announced that it would remove the heart disease, breast cancer, and dementia language from that boxed warning. It also dropped an old instruction telling doctors to use hormones “for the shortest possible time”, because that one line was pushing women off treatment even when they were still benefiting from it. Updated labels are being rolled out in stages.
One important warning stays. For women who take oestrogen on its own and still have their uterus, the warning about womb (endometrial) cancer remains. This particular risk is well understood and is usually managed by adding progesterone when appropriate. Your gynaecologist already factors this in.
Here is the quick way to think about it:
| Old fear | What the update actually means |
|---|---|
| “HRT always causes cancer” | Risk depends on your age, when you start, the type of therapy, and your personal history. |
| “Everyone should stop as soon as possible” | How long you stay on it should be reviewed individually, not by a fixed clock. |
| “Vaginal oestrogen is the same as hormone pills” | Local vaginal oestrogen works mainly in one area and carries different risk considerations. |
| “HRT is now risk-free” | No. It still needs a proper medical assessment. |
A typical menopause consultation pattern in our Kandivali clinic
The most common presentation I see is a woman aged 46 to 50, working or running a household, who has had irregular periods for the last year or two and recently started getting night sweats that break her sleep two or three times a week. She is exhausted by 4 pm and is wondering whether she is just “getting old” or whether something can actually be done. A friend or relative has told her HRT causes cancer, so she is half-relieved when she opens this article and finds that the picture is more nuanced. By the end of the first consultation we usually have a clearer picture of where she sits in the window-of-opportunity timeline, what her individual risk profile looks like, and which option (systemic HRT, vaginal-only oestrogen, non-hormonal treatment, or a watchful-waiting plan) fits her best.
What this does NOT mean
This is the part that matters most, so please read it twice.
The FDA did not say hormone therapy is risk-free. It did not say every woman should take it. What it said is that the warnings were out of date and painting a scarier picture than the evidence supports. More accurate, less frightening, not a free pass.
Women with a history of breast cancer, blood clots, stroke, or serious liver problems may not be suitable candidates for systemic hormone therapy and need individual medical assessment. For everyone else, it becomes a personal decision, made after a proper check-up and an honest conversation.
The thing most women get wrong: timing matters
Here is the idea that changed everything. Researchers call it the “window of opportunity”.
When the famous study that scared everyone, called the Women’s Health Initiative, was first reported in JAMA in 2002, most of the women in it were in their 60s, well past menopause. Years later, when scientists went back and studied the numbers more carefully, they noticed something they had missed: younger women, the ones who started hormone therapy before 60 or within about 10 years of menopause, had a very different and far more reassuring risk profile.
Think of it this way. Starting hormone therapy soon after menopause, while your blood vessels are still in good shape, is not the same as starting it fifteen years later. Same medicine, different body, different result.
For Indian women, this point matters even more, and here is why.
Why this matters more for Indian women
Indian women reach menopause earlier than women in the West. A pan-India survey by the Indian Menopause Society found the average age in India is around 46.2 years, compared with about 51 in Europe and America. Plenty of women in Mumbai notice the first changes in their mid-40s. The Indian Menopause Society’s Clinical Practice Guidelines on Menopause are the domestic reference standard your gynaecologist will draw on when assessing whether hormone therapy fits your situation.
That earlier timing means many women who walk into a clinic in their mid-to-late 40s with hot flushes are sitting right inside the “window of opportunity”, the phase where hormone therapy tends to be both safest and most useful.
“In my clinic I find that many women who had their last period at 44 or 45 come to me at 47 or 48 still thinking it is too soon to have a conversation about hormone therapy. They worry that talking about treatment means accepting they are old. The honest answer is that they are already inside the window when treatment, if it is right for them, works best. Waiting another five years is when the maths starts to change.”
- Dr. Pallavi Kulkarni
Two more things are specific to women here:
- Bone health. Vitamin D deficiency is very common in Indian cities, including Mumbai, even among women who get plenty of sunshine. Combined with earlier menopause, this raises the risk of weak bones and fractures in later life. Hormone therapy is one of the tools that helps protect bone, alongside calcium, vitamin D, and weight-bearing exercise.
- Heart and sugar risk. South Asian women are more prone to diabetes, high blood pressure, and cholesterol trouble, often at a lower body weight than women elsewhere. This does not rule out hormone therapy. But in some women, especially those with clotting or metabolic risk factors, your doctor may consider a patch or gel rather than a tablet, because trans-dermal oestrogen has less effect on liver-made clotting proteins.
Vaginal oestrogen vs systemic HRT: what is the difference?
A lot of the fear around hormones comes from mixing up two very different things.
Whole-body (systemic) hormone therapy means tablets, patches, gels, or sprays. These send hormones into your bloodstream and help with hot flushes (also called hot flashes), night sweats, sleep, mood, and bone health.
Local vaginal oestrogen means a small cream, tablet, or ring used directly in the vagina. It works mainly in one spot, with very little hormone reaching the rest of the body.
If your main troubles are vaginal dryness, discomfort during intimacy, or repeated urine infections after menopause, local vaginal oestrogen is usually the answer. The FDA specifically eased the warnings on these products because they behave so differently from pills.
| Form | What it treats | How much hormone reaches the body |
|---|---|---|
| Tablet (oral) | Hot flushes, night sweats, sleep, mood, bone protection | Highest; passes through the liver |
| Patch / gel / spray | Same as oral, but skips the liver | Whole-body but less effect on clotting / liver-made proteins |
| Vaginal cream / tablet / ring | Vaginal dryness, painful intercourse, recurrent UTIs after menopause | Very low; mostly stays where applied |
Many women feel shy bringing up vaginal symptoms. Please do not. They are extremely common and very treatable.
Who tends to benefit from hormone therapy?
Hormone therapy may be worth discussing if you have:
- Moderate to severe hot flushes or night sweats that are disrupting daily life or sleep
- Sleep that keeps breaking because of night sweats
- Vaginal dryness or pain during intercourse
- Menopause before 45, or very early menopause — starting hormone therapy is particularly important here because losing oestrogen earlier raises long-term bone and heart risks
- A higher risk of weak bones, especially if you cannot take other bone medicines
- Low mood or a clear drop in quality of life linked to menopause
- Cognitive symptoms — the “brain fog,” word-finding pauses, and short-term memory slips that many women describe in their late 40s and 50s
- New or worsening joint and muscle aches that started around the same time as your other menopausal symptoms (a real and under-recognised pattern)
Hormone therapy remains one of the most effective treatments for moderate to severe hot flushes and night sweats. There is also growing evidence that it can ease cognitive complaints and joint pain in women whose symptoms started during the menopause transition. That said, it should be chosen after weighing your own risks and the alternatives, not reached for as an automatic first step.
What if my periods have not stopped yet (perimenopause)?
Perimenopause is the four-to-eight-year transition before your last period. Cycles get irregular, hot flushes and night sweats start, sleep breaks up, and mood changes appear — even though you are still bleeding. You do not need to wait until your periods have stopped completely to be eligible for treatment. Many women in their early-to-mid 40s with disruptive perimenopausal symptoms are good candidates, particularly if menstrual cycles are already irregular. The decision still needs to be made with your gynaecologist after a full assessment, because pregnancy is still possible in perimenopause and treatment choices reflect that.
What checks happen before you start?
Before starting hormone therapy, your gynaecologist will usually:
- Take a careful personal and family history, especially of breast cancer, blood clots, and heart disease
- Check your blood pressure
- Order blood tests for sugar and cholesterol, which matters a lot for Indian women
- Make sure your breast check and cervical (Pap) screening are up to date
- Arrange a pelvic ultrasound if you have had any unusual bleeding
If you have had any bleeding after your periods had fully stopped for a year, tell your doctor about it before anything else. That always needs to be looked into.
What if you cannot or do not want hormones?
You still have good options.
Certain medicines originally developed for other conditions, particularly low-dose SSRIs (such as paroxetine), gabapentin, and clonidine, can reduce hot flushes. Newer non-hormonal medicines, such as fezolinetant (Veozah), target hot flushes directly through a different pathway. Veozah was approved by the FDA in 2023, and in 2024 the FDA added a warning about rare but serious liver injury, so women on it need blood-test monitoring. Fezolinetant is not yet approved by India’s Central Drugs Standard Control Organisation (CDSCO) and is not routinely available in Indian pharmacies as of mid-2026. The SSRIs, gabapentin, and clonidine are widely available in India and your gynaecologist can advise on whether one of them suits you.
Simple changes help too: dressing in light layers, keeping your bedroom cool, identifying which foods or drinks tend to trigger your flushes (spicy food, alcohol, caffeine for some), and a regular yoga and breathing practice. For vaginal dryness, moisturisers and lubricants give relief, though they do not work quite as well as vaginal oestrogen.
When should you see a gynaecologist for menopause treatment?
Book a visit if menopause symptoms are getting in the way of your sleep, work, mood, or relationships. You do not have to “manage on your own” or wait until things become unbearable.
See your doctor straight away if you have any vaginal bleeding after a full year without periods. And even when symptoms are mild, a yearly check during and after menopause is a healthy habit to build.
If you are in Kandivali or the western suburbs of Mumbai and want to talk through whether hormone therapy suits you, the menopause clinic at Aarogya Women’s Clinic can assess your symptoms, your history, and your personal risks, and help you arrive at the right decision together with Dr. Pallavi Kulkarni. We also serve patients across Kandivali West, Borivali, Malad, and Goregaon.
And if your previous doctor told you HRT was not safe, please remember that the conversation has genuinely shifted with the 2025 FDA update. A second opinion from a gynaecologist who specialises in menopause is a reasonable next step, not a sign that you are second-guessing your earlier care.
What kinds of HRT products are available in India?
In Indian clinics, your gynaecologist may consider any of these categories depending on your needs and history. This is not a self-treatment guide — brand and dose selection are clinical decisions.
- Oral oestradiol or conjugated oestrogens — tablet form, the most familiar option in India
- Oestradiol transdermal patches or gels — preferred where there is a clotting, metabolic, or migraine concern, since they bypass the liver
- Oral or vaginal progesterone (micronised) and progestogen tablets — needed alongside oestrogen for women who still have a uterus, to protect against endometrial cancer
- Local vaginal oestrogen (cream, pessary, or ring) — for vaginal dryness, painful intercourse, or recurrent UTIs after menopause
- Tibolone — a synthetic compound used in some cases as an alternative to combined HRT
Specific brand availability and pricing change over time and vary by pharmacy. We will tell you what is currently in stock and what fits your medical profile during your consultation.
What does a menopause consultation cost?
Consultation fees at our Kandivali East clinic are in line with private gynaecology rates in the western suburbs of Mumbai. For the current fee schedule, including any review-visit and procedure rates, please contact the clinic on +91 91366 33062 or WhatsApp. Hormone-therapy medications themselves are an additional, separate cost that depends entirely on the formulation prescribed; we will discuss expected monthly cost with you during the consultation before any prescription is written.
Confused about whether HRT is right for you after this FDA update? Book a 30-minute menopause consultation with Dr. Pallavi Kulkarni at our Kandivali East clinic.
References and further reading
The information in this article draws on guidance from the following bodies and publications. For specific medical advice for your situation, please consult your gynaecologist.
- U.S. Food and Drug Administration. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies (10 November 2025).
- The Menopause Society. Comments on the FDA Announcement on Hormone Therapy (2025).
- Harvard Health Publishing. FDA Removes Menopause Hormone Therapy Black Box Warnings (2025).
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33. PMID: 12117397.
- Ahuja M. Age of menopause and determinants of menopause age: A PAN India survey by IMS. Journal of Mid-life Health. 2016 Jul-Sep;7(3):126-131. PMID: 27721640.
- Meeta M, Digumarti L, Agarwal N, Vaze N, Shah R, Malik S. Clinical Practice Guidelines on Menopause: An Executive Summary and Recommendations: Indian Menopause Society 2019–2020. Journal of Mid-Life Health. 2020 Apr-Jun;11(2):55-95. PMC7688016.
- U.S. Food and Drug Administration. FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) (2024).
This article is for general awareness and education. It is not a substitute for personal medical advice. Hormone therapy is a decision that should always be made with a qualified gynaecologist after a proper assessment of your individual health.
Related reads on our blog
- → Menopause clinic in Kandivali East: when to come in and what to expect
- → Hormonal imbalance in women: signs, causes, and what to do
- → When to see a gynaecologist by age and life stage
- → Nutrient deficiency in Indian women: iron, vitamin D, B12 and the menopause years
- → Yoga for women’s health: poses, breathing and Yoga Nidra for menopause symptoms
Frequently asked questions
Is hormone therapy safe now?
It is safer than the old warnings made it sound, but it has never been completely risk-free and still is not. The FDA removed its boxed warnings in November 2025 because the bundled warnings about heart disease, breast cancer, and dementia were too broad and based on data from older women. For women who begin treatment before age 60 or within about 10 years of their last period, and who do not have certain medical conditions, the benefits often outweigh the risks. The decision is still personal and should be made with your gynaecologist.
Will HRT give me breast cancer?
For short-term use the increase in absolute risk is small. For women who use oestrogen alone after a hysterectomy, several studies even suggest a slightly lower breast cancer risk. The risk is mostly linked to longer-term combined therapy. This is exactly the kind of trade-off to weigh up with your gynaecologist, based on your personal and family history.
Kya hormone therapy lena safe hai?
Dekhiye, hormone therapy ko lekar kaafi galat baatein faili hui hain. Sach yeh hai ki agar aap 60 saal se kam umar ki hain, ya aapke periods band hue 10 saal se kam hua hai, aur aapko koi badi medical problem (jaise breast cancer ya blood clot ki history) nahi hai, toh hormone therapy kaafi surakshit aur faydemand ho sakti hai. November 2025 mein FDA ne bhi hormone therapy par lagaye gaye purane warnings hata diye hain kyunki yeh warnings purani research par based the. Lekin yeh har kisi ke liye nahi hai. Sahi rasta yeh hai ki aap apni gynaecologist se apni poori health history discuss karein, kuch zaroori test karwayein, aur phir saath milkar faisla lein.
I stopped HRT years ago because I was scared. Should I think about it again?
Possibly, but it depends on your age now and how long it has been since menopause, because the timing point really matters. The further past menopause you are when you restart, the smaller the benefit and the higher the relative risk. Bring it up at your next visit rather than restarting on your own.
I have diabetes and high blood pressure. Can I still take it?
It depends on the severity of your condition. For many women with well-controlled diabetes or high blood pressure, a gynaecologist may consider the patch or gel rather than oral tablets, because trans-dermal oestrogen has less effect on clotting and metabolic markers. Your doctor will want your sugar and blood pressure reasonably under control and will review your latest blood results before making any decision.
How long can I stay on hormone therapy?
There is no fixed limit that fits everyone. Many women use it for a few years to get through the worst phase and then slowly taper. Some continue for longer with good reason, especially for ongoing symptoms or bone protection. The FDA specifically dropped the old “shortest possible time” language because it was pushing women off treatment too early. You and your doctor should review it at least once a year.
What is the difference between systemic HRT and vaginal oestrogen?
Systemic HRT means tablets, patches, gels, or sprays that send hormones into your bloodstream. It treats hot flushes, night sweats, sleep disturbance, mood symptoms, and protects bone. Local vaginal oestrogen means a small cream, tablet, or ring used directly in the vagina. It works mainly in one area for vaginal dryness, painful intercourse, and recurrent UTIs in post-menopausal women, with very little hormone reaching the rest of the body. The FDA specifically eased its warnings on vaginal oestrogen because the systemic risks do not really apply to it.
What is the “window of opportunity” for HRT?
It is the phrase researchers use for the years between when your periods stop and roughly your early 60s, when starting HRT tends to be both safest and most useful. Beginning HRT during this window, when your blood vessels are still in good shape, is associated with a better risk profile than starting it 15 or 20 years after menopause. For Indian women who often reach menopause around age 46, this window opens earlier than for women in the West.
What if I do not want hormones at all?
You have options. Certain antidepressants and gabapentin reduce hot flushes for many women and are widely available in India. Fezolinetant (brand name Veozah, FDA-approved in 2023) is a newer non-hormonal medicine specifically for hot flushes; it carries a boxed warning for rare liver injury, needs blood-test monitoring, and is not yet approved by CDSCO in India as of mid-2026, so it is not routinely available in Indian pharmacies. For vaginal dryness, moisturisers and lubricants give relief, though not as completely as vaginal oestrogen. Lifestyle changes (light layers, cool bedroom, identifying trigger foods) also help.
When should I see a gynaecologist for menopause?
Book a visit if menopause symptoms are getting in the way of your sleep, work, mood, or relationships. You do not have to manage on your own or wait until things become unbearable. See your doctor straight away if you have any vaginal bleeding after a full year without periods. Even when symptoms are mild, a yearly check during and after menopause is a healthy habit. If you are in Kandivali or the western suburbs of Mumbai, the menopause clinic at Aarogya Women’s Clinic can help.
Not sure after all of this? That is normal.
The whole point of the FDA update is that the HRT decision is more personal than the old warnings allowed. Book a 30-minute menopause consultation with Dr. Pallavi Kulkarni at our Kandivali East clinic, and we will go through your situation together — calmly, without rushing, and with the latest evidence in hand.
Book a menopause consultationWhat Our Patients Say
Experienced Gynecologist in Kandivali East with a Patient-Centered Approach
Dr. Pallavi Kulkarni is a highly regarded Gynecologist in Kandivali East, praised for her calm, compassionate, and patient-centered care. Her supportive approach helps women feel heard, respected, and confident about their treatment decisions.